Background Stroke disproportionately affects people in low-income and middle-income countries. Although improvements in stroke care and outcomes have been reported in high-income countries, little is known about practice and outcomes in low and middle-income countries. We aimed to compare patterns of care available and their association with patient outcomes across countries at different economic levels.
Introduction
Stroke is the second most common cause of death worldwide and one of the leading causes of disability. [1] [2] [3] Although prevention strategies can reduce this burden of disease, 4, 5 effective and affordable treatments are essential for reducing mortality and morbidity in those who have already had a stroke. Aspirin, 4, 5 intravenous thrombolysis, 4, 5 and mechanical thrombectomy 6 for acute ischaemic stroke, plus stroke unit care and early rehabilitation services for all stroke patients 4, 5 can reduce mortality and morbidity.
Results of the 2014 PURE study 7 showed that clinical outcomes after stroke were substantially poorer in low-income and middle-income countries than in high-income countries. Whether this finding reflects differences in the patient population, services available, or treatments received is uncertain. In many high-income countries, clinical practice guidelines and national strategies now recommend the establishment of stroke units in all hospitals that care for patients with acute stroke. [8] [9] [10] [11] [12] [13] This practice has been linked to an increased provision of evidence-based care [14] [15] [16] [17] [18] [19] and improved patient outcomes. [17] [18] [19] [20] However the greatest adoption of these practices has been in high-income countries, where most clinical trials of stroke units have been done. The number of stroke units in low-income and middle-income countries is unknown, along with whether these are associated with improved outcomes. 4, 5, 8 Such information could inform the establishment of stroke units in lowincome and middle-income countries.
INTERSTROKE was an international observational stroke study done in 32 countries at different economic levels. 21 Individuals who had had a stroke were selected using standardised criteria and were characterised in detail. In this study we use INTERSTOKE data to compare patterns of care available and their association with patient outcomes, across a much broader range of health-care settings than has previously been possible.
Methods

Study design and participants
INTERSTROKE was an international case-control study of risk factors for first stroke, 21 which enrolled 13 447 stroke patients from 142 clinical sites in 32 countries between Jan 11, 2007 , and Aug 8, 2015 . For this analysis of practice patterns, our hypotheses were that, across all countries studied, there would be variations in access to stroke treatments and services and that, after adjusting for variations in patient casemix, patient outcomes would be affected by the treatments and services they can access. We proposed that outcomes would be better where health-care resources were greater, guideline investigations and treatments were provided, and guideline services (especially stroke units) were available at the hospital.
Data collection operated at two levels. First, individual stroke patient data included the following: demographic features (age, sex, level of education), risk factors, prestroke disability (using the modified Rankin Scale 22 ), comorbidity (based on the Charleston Comorbidity Index 23 ), stroke characteristics (including haemorrhage or infarct classified with the Oxfordshire Community Stroke Project classification, 24 modified Rankin score 22 at baseline, level of consciousness at baseline), and acute management received at enrolment in the study (brain imaging, antiplatelet treatment, thrombolysis, lipid-lowering treatment, and blood pressure-lowering treatment).
Second, service-level data were collected. Using a short questionnaire (appendix), we collected information about service features at every participating hospital: local and national health-care characteristics (eg, source of health funding and items for payment); hospital characteristics and resources (eg, tertiary or secondary level hospital, and departments and beds available); stroke service characteristics (eg, presence of stroke unit and stroke unit characteristics and resources); and additional features (ie, other aspects of patient care such as postdischarge rehabilitation). The survey was first circulated by e-mail from the coordinating centre via national leads in June, 2011; if there was no reply by early 2012, the e-mail was re-sent.
The study was approved by the ethics committees in all participating centres. 21 Participants, or their proxy, provided written informed consent.
Outcomes
Patient outcomes were recorded at 1 month follow up 21 and included death, discharge disposition after hospital (home, rehabilitation centre, or nursing home), dependency using the modified Rankin score, 22 and length of hospital stay. Patient details were collected from the participants or from a proxy respondent.
21
Statistical analysis
We described patient characteristics and clinical practice (ie, investigations, treatments, and services provided) at recruiting hospitals grouped by the 2011 World Bank Country Income Categories using χ² and t tests.
Research in context
Evidence before this study We searched MEDLINE, Embase, and PubMed from Jan 1, 2000, to May 24, 2017, for large stroke register studies using Medical Subject Headings including the following search terms: "stroke OR cerebral hemorrhage OR cerebral infarction AND quality indicator OR performance indicator OR quality improvement OR quality of care OR quality of health care OR registry OR register OR audit AND outcome OR mortality OR case fatality OR survival OR disability OR function OR recovery OR discharge OR discharge destination OR return home OR complications". We identified 20 studies but none had been done in low or middle-income country settings.
Added value of this study
This is the first large study to use standardised, prospective data collection across a range of World Bank country income categories levels in more than 12 000 carefully characterised acute stroke patients from 108 hospitals in 28 countries. We have found that evidence-based treatments, diagnostics, and availability of stroke units were less common in low-income and middle-income countries. Access to stroke units and appropriate antiplatelet treatment were consistently associated with improved recovery.
Implications of all the available evidence
This analysis supports the widespread provision of appropriate early antiplatelet treatment and stroke unit care within hospitals in low-income and middle-income country settings. A certain basic standard of care and supporting resources are likely to be needed to fully achieve these benefits. Further research needs to develop and test methods of effectively implementing lower-cost, regionally appropriate models of stroke unit care.
We did multivariate analyses using SPSS (version 23) and SAS (version 9.4) to calculate casemix adjusted outcomes and a two-level multivariable model using random intercepts to take into account potential clustering of clinical practice by centre. We used multivariable logistic regression models to adjust for casemix covariates that are known to affect patient outcomes 25 -ie, age, sex, level of education, pre-stroke disability, number of comorbidities, stroke type and classification, and initial stroke severity. No significant multi-collinearity was identified. Adjustment was also made for country wealth (ranked by gross domestic product [GDP] ) and clustering by centre. We then used binary logistic regression to identify variables that had the closest association with patient outcomes. Subgroup analyses stratified results by key patient and service characteristics. Availability of a stroke unit was clustered in regions and correlated with patient age, level of consciousness, and stroke severity. Therefore we also sought to confirm our findings in a propensity-matching analysis accounting for these variables. Finally, we did exploratory sensitivity analyses of the association between patient outcomes and access to stroke units (with or without particular characteristics). These comparisons were based on stroke unit quality criteria 26 in terms of the following: the presence of a discrete ward, multidisciplinary care, staff specialist interest in stroke, programmes of staff education, patient management protocols, and information for patients and families; staffing levels that meet basic benchmark levels for nursing and medical and treatment staff; 26 stroke unit capacity (ability to manage >50% of the stroke patients in the hospital); and access to postdischarge rehabilitation.
Role of the funding source
The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data and final responsibility for the decision to submit for publication. in blood pressure-lowering treatments and lipidlowering treatment were not linked clearly to World Bank country income categories. Data reporting was almost complete (12 266; 99%) for all reported variables with the exception of thrombolysis and carotid interventions for which non-reporting was assumed to indicate that the treatment was not given. Table 1 also summarises the services available in each site. 6055 (49%) patients were admitted to hospitals reporting that they had some form of stroke unit available; (95% of centres and 92% of patients in high-income countries; 30% of centres and 38% of patients in low-income and middle-income countries). However there was no clear gradient by World Bank country income categories, with the fewest stroke units being available in upper-middle-income countries. When present, stroke units in low-income and middle-income countries were less likely to meet all of the six key quality characteristics 26 or to report having sufficient capacity to accommodate most hospitalised stroke patients (table 1) . This was corroborated by information that, for the same number of admissions (a median of 50 stroke patient admissions per month), stroke units in high-income countries reported having a median of 18 beds available compared with eight beds in units in low-income and middle-income countries.
Results
Between
Stroke patients from wealthier countries had better outcomes at 1 month. When grouped as high-income countries versus low-income and middle-income countries, the number surviving, and surviving without major dependency, as defined by a modified Rankin Scale score of 0-3, were 2501 (98%) and 2308 (90%), respectively in high-income countries compared with 8580 (88%) and 7536 (78%) in low-income and middle-income countries. This finding was confirmed when outcomes were regressed against country wealth; ranked from lowest to high est country GDP (table 2) . Differences in patient character istics seemed to explain much, but not all, of the variation by country wealth. After adjusting for baseline patient casemix variables (age, sex, education, pre-stroke disability, stroke type, number of comorbidities, level of consciousness, and modified Rankin score at baseline) the association between country income and recovery was reduced but not abolished (table 2) . There was no further attenuation of the association after including common drugs given (antiplatelet, lipid lowering, and BP-lowering treatment and thrombolysis), and access to services (medical stroke specialist, stroke unit, and rehabilitation post discharge). These results suggest that the incrementally better patient outcomes recorded in wealthier countries were partly explained by patient casemix.
We then explored the associations between treatments given, services available, and patient outcomes across all World Bank country income category settings (table 3) . For these analyses we included all treatments and services that were less common in centres in low-income and middle-income countries (table 1) . We did not include carotid interventions because this applied to only 97 (1%) patients overall. After adjustment for patient casemix and country wealth, the appropriate provision of antiplatelet treatment (prescribed for those with cerebral infarction), and the availability of stroke unit care and post-discharge rehabilitation were each associated with a greater chance of survival without severe dependency (table 3) . The appropriate provision of antiplatelet treatment and availability of stroke unit care and postdischarge rehabilitation were also associated with a Data are n, mean (SD), or n (%). All recruited patients were expected to have brain imaging (usually a CT scan) and a 12-lead electrocardiogram. mRS=modified Rankin Scale. BP=blood pressure. *Substantial missing data that were assumed to suggest non-treatment. †Usually carotid endarterectomy (a few patients had carotid stenting). ‡The stroke unit characteristics included 26 discrete ward, staff who specialise in stroke, regular multidisciplinary team meetings, protocols for care in place, programmes of education and training for staff, information provided for patients and carers. §Basic stroke unit staffing was benchmarked 26 at a staff complement (to cover all shifts) of 1·0 whole time equivalent of nursing staff per bed, 0·1 whole time equivalent of therapist, and 0·1 whole time equivalent of doctor. All comparisons are at the level of the patient. Because the services available were clustered at centres, we also confirmed any differences at the level of the centres. higher probability of survival at 1 month (table 3) . When the analysis also took into account clustering by centre (table 3) , the availability of stroke unit care and postdischarge rehabilitation were each associated with a greater chance of survival without severe dependency (table 3) . The appropriate provision of antiplatelet treatment and availability of post-discharge rehabilitation were associated with a higher chance of survival at 1 month when taking into account clustering by centre. Using a forward binary logistic regression, including all variables listed in table 3, we noted that survival without severe dependency as defined by modified Rankin Scale 0-3 was greater with access to stroke unit care and appropriate antiplatelet treatment. Significant covariates were pre-stroke disability plus the five patient variables (age, comorbidities, baseline modified Rankin Scale, level of consciousness, and stroke classification). Survival at 1 month was best explained by appropriate antiplatelet treatment, access to stroke unit care, and access to postdischarge rehabilitation. Significant covariates were country GDP ranking, patient education, and the five patient variables above. Table 4 highlights the univariate and multivariate analyses exploring the association of access to a stroke unit with the provision of other stroke treatments and with patient outcomes. Admission to a hospital with a stroke unit was associated with increased odds of receiving all the other process measures plus increased survival and survival without severe dependency. However after adjusting for clustering by centre, access to a stroke unit was only associated with increased access to CT scanning and post-discharge rehabilitation and with survival without severe dependency (1·29; 1·14-1·44).
As stroke unit availability was unevenly distributed between regions, we used a matched propensity analysis that excluded the five regions where availability was either universal (western Europe, eastern Europe, North America, and Australia) or absent (Middle East). Variables that were related to patient outcomes and also closely 
1·06 (1·04-1·07); p<0·0001
Data are odds ratio (95% CI); p value. Exploration of the association between country wealth and odds of patients having a better outcome (graded by the modified Rankin Scale; mRS) and the gross domestic product (GDP) ranked from lowest to highest income. The univariate analysis includes only country GDP ranked from the highest to lowest of the 28 included countries. *Outcomes adjusted for country GDP ranking plus participant age, sex, education, pre-stroke disability, stroke type (haemorrhage or Oxfordshire Community Stroke Project category of infarct), number of comorbidities (Charleston comorbidity index), level of consciousness, and modified Rankin score at baseline (always recorded within 5 days of stroke onset). †Outcomes adjusted for all of the above plus common drugs given (antiplatelet, lipid-lowering, blood pressure-lowering treatment, and thrombolysis). ‡Outcomes adjusted for all of the above plus accounting for services available (medical stroke specialist, stroke unit, and rehabilitation post discharge). §Outcomes adjusted for those in ‡ plus clustering by centre. 
1·54 (1·28-1·85); p<0·0001
Data are odds ratio (95% CI); p value. The multivariate analysis used multivariate regression to show casemix adjusted outcomes. mRS=modified Rankin Scale. *Outcomes adjusted for participant age, sex, education, pre-stroke disability, stroke type (haemorrhage or Oxfordshire Community Stroke Project category of infarct), number of comorbidities (Charleston comorbidity index), level of consciousness, and modified Rankin score at baseline (always recorded within 5 days of stroke onset). †Outcomes adjusted for all of the above plus country income (GDP ranking). ‡Outcomes adjusted for all those in † plus centre. §Service available at the recruiting centre but not necessarily received by every patient. Table 3 : Association of treatments available with patient outcomes at 1 month associated with stroke unit availability were patient age and stroke severity. Therefore, we compared two groups of 3466 stroke participants with or without access to a stroke unit who were matched on age (mean age, years), reduced level of consciousness (45%), and baseline modified Rankin Scale score (mean score 3·40). Admission to a hospital that had a stroke unit was again associated with increased odds of survival (1·15; 1·01-1·31) and of survival without major disability (1·30; 1·17-1·44).
In view of the imbalance between high-income countries and low-income and middle-income countries in the numbers of patients with intracerebral haemorrhage, we repeated the analyses excluding intracerebral haemorrhages (appendix). On multivariate analyses, patients with ischaemic stroke had increased survival without severe dependency (1·42; 1·23-1·64; p<0·0001) if admitted to a hospital with a stroke unit. Results were directionally consistent but non-significant for survival (1·15; 0·96-1·39; p=0·14).
Further subgroup analyses found a consistent association between access to stroke unit services and patient outcomes across a range of patient and service subgroups ( figure 1) . The association of improved outcomes with antiplatelet drug use was seen across all subgroups (figure 2) except for stroke type where no benefit was recorded for the very small number of haemorrhage patients given aspirin.
Finally, in sensitivity analyses we repeated the analysis in table 4 for the outcome of survival without severe dependency (modified Rankin Scale 0-3) but compared stroke units with and without specific quality characteristics (as described in table 1 ). The association with improved outcomes was greater in the presence of quality features compared with absence: if the stroke unit was described as having the six key characteristics (1·32; 1·11-1·56); if stroke unit staffing met basic benchmark levels (1·34; 1·11-1·62); and if the stroke unit had the capacity to house at least 50% of stroke patient admissions (1·20; 1·00-1·45). The availability of postdischarge rehabilitation was not associated with additional benefit in this analysis (1·08; 0·67-1·33).
Discussion
We had anticipated that INTERSTROKE patients enrolled from hospitals in low-income and middleincome countries would have poorer access to investigations, treatments, and services than those enrolled from hospitals in high-income countries. However, these patients also had poorer clinical outcomes (survival 88% vs 98% in high-income countries; survival without severe disability 78% vs 90%), which could only be partly explained by the inclusion of more severe stroke patients. Across all countries studied, the practice variables most consistently associated with improved patient outcomes were access to stroke unit care and post-discharge rehabilitation plus receiving appropriate antiplatelet treatment. This could reflect more limited access to state or insurance-funded health-care services.
The poorer stroke prognosis in low and middle-income countries has been described previously. 2, 3, 7, 27 We have confirmed that stroke in poorer countries seems to be either a more severe disease (ie, more intracerebral haemorrhage) or has different referral patterns (patients admitted to hospital are more likely to have severe stroke). The potential role of stroke units and antiplatelet treatment in low-income and middle-income country settings has not been described before but is potentially complex. Access to drugs or services could not explain differences between patient outcomes in wealthy versus less wealthy countries but they did seem to explain associations across all countries. This might reflect the observation that access to a stroke unit varied greatly within as well as between wealth categories.
Several observational studies 16, 18, 20, 28 have reported on the association of appropriate antiplatelet treatment (ie, early use in acute cerebral ischaemia) with improved survival and reduced disability. Additionally, a 2016 meta-analysis of aspirin trials 29 confirmed an important Data are n (%) or odds ratio (95% CI); p value. The table shows the number (%) of patients in both service groups in each category of process measure (care received up to 1 month) and outcome measure (degree of recovery at 1 month post stroke). Univariate analyses show the unadjusted odds ratio and 95% (CI) for the association between access to stroke unit care and a better clinical outcome. The multivariate analysis used multivariate regression to show casemix adjusted outcomes. BP=blood pressure. mRS=modified Rankin Scale. *Outcomes adjusted for participant age, sex, education, pre-stroke disability, stroke type (haemorrhage or Oxfordshire Community Stroke Project category of infarct), number of comorbidities (Charleston comorbidity index), level of consciousness, and modified Rankin score at baseline (always recorded within 5 days of stroke onset), plus country income (GDP ranking). †Outcomes adjusted for all of the above plus centre. Table 4 : Association of access to stroke unit care with processes of care and patient outcomes at 1 month short-term benefit of aspirin treatment to prevent recurrent cerebral ischaemia. However, these studies have almost all been done in high-income settings. 27, 28 Earlier access to brain imaging could facilitate earlier antiplatelet use.
In the INTERSTROKE study, the apparent benefit of stroke units is similar to that reported in randomised clinical trials 4 and seems to be due to a combination of an intrinsic stroke unit effect as well as stroke unit patients having better access to antiplatelet treatment, risk factor modification, and post-discharge rehabilitation. The apparent benefits were recorded across a range of stroke patient groups and tended to be greater if the stroke unit was reported to be well staffed, to meet recognised service standards, and to have sufficient capacity to provide care for most stroke patients admitted to hospital. Our findings suggest that stroke units can have a similar benefit in low-income and middle-income countries as has been noted in high-income countries.
At present few hospitals in low-income and middleincome countries have stroke units. Even in our study, which is likely to have included a higher proportion of better-resourced tertiary care centres (with better access to imaging and drug therapies) than in most hospitals in low-income and middle-income countries, only 38% had stroke units. Our study suggests that establishment of simple stroke units could enhance the level and organisation of care and improve stroke outcomes in low-income and middle-income countries. WHO has targeted a 25% reduction in premature mortality from cardiovascular disease globally by 2025. This is unlikely to be achieved by risk-factor reduction alone but also requires investment in medical treatments and organisation of better systems of care. Investment in specialised stroke units is likely to be cost effective and should be a priority worldwide.
Limitations of this study include the observational design, which cannot completely exclude the possibility of residual confounding. We did several analyses, which raises the possibility of chance findings. However, use of the 99% confidence threshold would not alter our main conclusions. Service features were described at the level of the hospital so we cannot be certain which specific patients were actually admitted to a stroke unit. Although this introduces some uncertainty, it also reduces any potential bias resulting from selective admission of patients with better prognosis within a hospital to the stroke unit; it is testing the effect of the stroke unit on all patients at that hospital. Of note, the sensitivity analyses suggest improved outcomes where stroke units had greater capacity to accept most stroke patients. As only a proportion of patients were enrolled in INTERSTROKE, it is possible (but unlikely) that stroke unit sites enrolled patients with a better prognosis. An additional challenge was that service characteristics tended to cluster together in hospitals, countries, and regions making it difficult to separate the effect of different aspects of service delivery. In particular, the availability of post-discharge rehabilitation services was closely related to stroke units. Finally, several regions had no variation in the provision of stroke units, although exclusion of these regions from the analysis did not alter our conclusions. The strengths of our study are that we collected standardised information from more than 12 000 well characterised acute stroke patients including an independent assessment of outcome at 1 month. We recruited from a large number of hospitals in diverse settings with variations in care. This was facilitated by national coordinators and investigators who were trained in collecting data in a standardised manner. The study investigators had a research interest in stroke epidemiology, but there was not usually a special interest in service delivery. Although we recognise that the hospitals participating in INTERSTROKE are likely to have had a higher level of resources and support than is typical of poorer resourced areas, we know of no other study that has obtained such a broad range and quality of data using such standardised and prospective methods. If the centres participating in INTERSTROKE were better equipped than the average centres in each country (especially in low-income and middle-income countries), the gaps between high-income countries and low-income and middle-income facilities, organised care, treatments, and outcomes for stroke patients might be even greater than what we report.
Several previous studies have explored the potential effect of indicators of service quality in routine hospital settings; 27, 28 however, almost all have been done in highincome countries. The most recent review of low and middle-income countries 8 could only identify limited observational information that could not adjust for confounders. Individual case studies in India, Thailand, South Africa, and Mauritania 8 suggested that stroke unit care could have a beneficial effect in those settings. Only two studies have explored the effect of antiplatelet agents in low-income and middle-income countries and their results were inconclusive. 28 In conclusion, we believe that this analysis supports the widespread provision of appropriate early antiplatelet treatment and stroke unit care within hospitals in lowincome and middle-income settings. It also indicates that a certain basic standard of care and supporting resources are likely to be needed to fully realise these benefits. These include adequate staffing and the capacity to accept the majority of stroke patients. Further research needs to develop and test methods of effectively implementing lower-cost, regionally appropriate models of stroke unit care.
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